Oncotech Nordic

Tackling the Global Cancer Crisis with Affordable Early Detection

Cancer is one of the world's most urgent health challenges — responsible for nearly 10 million deaths in 2020, or one in six globally. And the crisis is growing: global cancer diagnoses are projected to reach 35 million by 2050, a 77% increase from 2022, according to the World Health Organization.

Early detection saves lives, but access to effective screening remains uneven, costly, and often unavailable in high-risk regions. Oncotech is developing iris scan technology that may offer a breakthrough: affordable, non-invasive pre-screening that can identify early indicators of the world's most common cancers — including lung, breast, cervical, uterine, prostate, and colon cancers — using just a single eye image.